Condensed Consolidated Statements of Stockholders' Equity - USD ($)	Total	Preferred Stock Series A Convertible Preferred Stock	Common Stock	Additional Paid-In Capital	Accumulated Other Comprehensive Loss	Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2021		1,250
Beginning balance at Dec. 31, 2021	$ 179,746,436	$ 1	$ 70,359	$ 351,033,589	$ 0	$ (171,357,513)
Beginning balance (in shares) at Dec. 31, 2021			70,364,912
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock from exercise of stock options and purchases from employee stock purchase plan (in shares)			52,333
Issuance of common stock from exercise of stock options and purchases from employee stock purchase plan	33,079		$ 14	33,065
Stock-based compensation expense	1,324,812			1,324,812
Net (loss) income	(16,108,056)					(16,108,056)
Ending balance (in shares) at Mar. 31, 2022		1,250
Ending balance at Mar. 31, 2022	$ 164,996,271	$ 1	$ 70,373	352,391,466	0	(187,465,569)
Ending balance (in shares) at Mar. 31, 2022			70,417,245
Beginning balance (in shares) at Dec. 31, 2022	1,250	1,250
Beginning balance at Dec. 31, 2022	$ 132,272,564	$ 1	$ 70,467	357,770,825	(42,187)	(225,526,542)
Beginning balance (in shares) at Dec. 31, 2022	70,466,885		70,466,885
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock from exercise of stock options and purchases from employee stock purchase plan (in shares)			24,625
Issuance of common stock from exercise of stock options and purchases from employee stock purchase plan	$ 66,993		$ 25	66,968
Stock-based compensation expense	1,916,518			1,916,518
Other comprehensive income	47,817				47,817
Net (loss) income	$ (13,356,209)					(13,356,209)
Ending balance (in shares) at Mar. 31, 2023	1,250	1,250
Ending balance at Mar. 31, 2023	$ 120,947,682	$ 1	$ 70,492	$ 359,754,310	$ 5,630	$ (238,882,751)
Ending balance (in shares) at Mar. 31, 2023	70,491,510		70,491,510